Intravenous Nesiritide vs Nitroglycerin for Treatment of Decompensated Congestive Heart Failure

Abstract

When added to standard care in patients hospitalized with acutely decompensated CHF, nesiritide improves hemodynamic function and some self-reported symptoms more effectively than intravenous nitroglycerin or placebo.